FILE - In this Feb. 4, 2021, file photo released by Imam Khomeini Airport City, Russian-made Sputnik V COVID-19 vaccines are unloaded at the Tehran's Imam Khomeini International Airport. Russia's boast in August that it was the first country to authorize a coronavirus vaccine led to skepticism because of its insufficient testing on only a few dozen people. Now, with demand growing for the Sputnik V, experts are raising questions again, this time over whether Moscow can keep up with all the orders from countries that want it. (Saeed Kaari/IKAC via AP, File)
The Associated Press
MILAN (AP) - Russia has signed a deal to produce its Sputnik V coronavirus vaccine in Italy, the first contract in the European Union, the Italian Russian Chamber of Commerce announced Tuesday.
The deal was signed with Adienne Srl, the Italian subsidiary of a Swiss-based pharmaceutical company, and Kirill Dmitriev, CEO of the Russian Direct Investment Fund. Production is set to start in July and produce 10 million doses this year.
'Å“The innovative production process will help create new jobs and allow Italy to control the entire production of the compound,'' the chamber said in a statement. Financial terms were not released.
Russian authorities are working on 20 similar collaborations in Europe and the Sputnik V vaccine has been registered in 45 nations worldwide, the group said.
The Russian Direct Investment Fund that bankrolled the vaccine and markets it abroad has said that the production of Sputnik V will span several countries, including India, South Korea, Brazil, China, Turkey, Iran, as well as Belarus and Kazakhstan. Some manufacturers abroad have produced trial batches of the Russian vaccine, but there are few indications they have so far produced any large amounts of the shot.
___
- Follow AP's pandemic coverage at https://apnews.com/hub/coronavirus-pandemic, https://apnews.com/hub/coronavirus-vaccine and https://apnews.com/UnderstandingtheOutbreak
FILE - In this Jan. 20, 2021, file photo, a Russian medical worker, right, administers a shot of Russia's Sputnik V coronavirus vaccine to a patient in a vaccination center in Moscow, Russia. Russia's boast in August that it was the first country to authorize a coronavirus vaccine led to skepticism because of its insufficient testing on only a few dozen people. Now, with demand growing for the Sputnik V, experts are raising questions again, this time over whether Moscow can keep up with all the orders from countries that want it. (AP Photo/Pavel Golovkin, File)
The Associated Press
FILE - In this Feb. 24, 2021, file photo, a medical worker injects a woman with a dose of the Russian COVID-19 vaccine Sputnik V at the Palacio de los Deportes, in the Iztacalco borough of Mexico City. Russia's boast in August that it was the first country to authorize a coronavirus vaccine led to skepticism because of its insufficient testing on only a few dozen people. Now, with demand growing for the Sputnik V, experts are raising questions again, this time over whether Moscow can keep up with all the orders from countries that want it. (AP Photo/Rebecca Blackwell, File)
The Associated Press
FILE - In this Aug. 6, 2020, file photo provided by Russian Direct Investment Fund, a COVID-19 vaccine is on display at the Nikolai Gamaleya National Center of Epidemiology and Microbiology in Moscow, Russia. Russia's boast in August that it was the first country to authorize a coronavirus vaccine led to skepticism because of its insufficient testing on only a few dozen people. Now, with demand growing for the Sputnik V, experts are raising questions again, this time over whether Moscow can keep up with all the orders from countries that want it. (Alexander Zemlianichenko Jr/ Russian Direct Investment Fund via AP, File)
The Associated Press